| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 02/13/2001 | US6187780 Antidepressants, antiasthmatic agents; migraine |
| 02/08/2001 | WO2001009134A1 Purine derivatives inhibitors of tyrosine protein kinase syk |
| 02/06/2001 | US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites |
| 02/06/2001 | US6184376 Potent antivirals, especially against herpes infections, such as those caused by varicella zoster virus, herpes simplex, epstein-barr virus, herpes type 6 (hhv-6) and type 8 (hhv-8). shingles in the elderly or chicken pox in the young |
| 02/06/2001 | US6184235 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 02/01/2001 | WO2001007441A1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES |
| 02/01/2001 | WO2000008041A9 Structural analogs of amine bases and nucleosides |
| 02/01/2001 | CA2380181A1 8-phenyl-6,9-dihydro-¬1,2,4|triazolo¬3,4-i|purin-5-one derivatives |
| 01/31/2001 | CN1282329A I (ortho)-anthranilamide derivatives as anti-coagulants |
| 01/30/2001 | US6180791 Synthesis of 8-substituted xanthines |
| 01/30/2001 | US6180615 Propargyl phenyl ether A2A receptor agonists |
| 01/25/2001 | WO2001005771A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 01/25/2001 | DE19933164A1 Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with 5,6-substituted pyrimidine ring, their preparation and use as endothelin receptor antagonists |
| 01/25/2001 | CA2379545A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 01/24/2001 | EP1070076A1 Chiral separations of pyrimidines |
| 01/24/2001 | EP1070052A1 Fungicide compositions comprising a hydroximic or hydrazonic group |
| 01/24/2001 | CN1281458A Purine compounds having PDE IV inhibitory activity and methods of synthesis |
| 01/24/2001 | CN1281457A process for synthesis of chloropurine intermediates |
| 01/23/2001 | US6177428 Treatment of sexual dysfunction; stimulation of endogenous nitrogen monoxide synthesis |
| 01/23/2001 | US6177280 Ricin inhibitors and methods for use thereof |
| 01/18/2001 | WO2001004134A2 Novel esters derived from nucleosides, preparation methods and pharmaceutical compositions containing them |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/18/2001 | CA2374411A1 Novel esters derived from nucleosides, preparation methods and pharmaceutical compositions containing them |
| 01/17/2001 | EP1069110A1 Sulfonamide derivatives |
| 01/17/2001 | EP1068210A2 Process for the production of purine derivatives |
| 01/17/2001 | EP1068209A1 Process for the production of purine derivatives and intermediates therefor |
| 01/17/2001 | CN1280579A Novel polymorphic forms of cipamfylline |
| 01/17/2001 | CN1280560A Adamantane derivatives |
| 01/16/2001 | US6175008 Viricides from reaction mercaptoaldehyde with acetoester and 1,4-dithiane-2,5-diol |
| 01/16/2001 | US6174907 Therapy and prophylaxis of hyperlipemia or arterial sclerosis; as additive of a silver halide photosensitive material, liquid crystal material |
| 01/11/2001 | WO2001002400A1 Fused imidazole compounds and remedies for diabetes mellitus |
| 01/11/2001 | WO2001002399A1 Substituted purine derivatives as inhibitors of cell adhesion |
| 01/11/2001 | WO2001002398A1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 01/11/2001 | CA2376673A1 Substituted purine derivatives as inhibitors of cell adhesion |
| 01/10/2001 | EP1067123A1 Nitrogenous heterocyclic compounds |
| 01/10/2001 | EP1066266A1 Cyclin dependent kinase inhibitors |
| 01/09/2001 | US6172226 Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions |
| 01/09/2001 | US6172224 Process for isolating 2-amino-6-chloro-9-[(1'S,2'R)-1'2'-bis(hydroxymethyl)-cyclopropane-1'-YL]methylpurine and an optical isomer thereof |
| 01/09/2001 | US6172103 Treating bone disorders, osteoporosis, and arthritis |
| 01/09/2001 | US6172070 In polyoxyethylene glycol carrier |
| 01/09/2001 | US6172068 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 01/09/2001 | US6172060 Therapy for sexual disorders |
| 01/04/2001 | WO2001001135A1 Enzyme inhibition immunoassay |
| 01/04/2001 | WO2001000587A1 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 01/04/2001 | WO2001000578A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 01/04/2001 | WO2001000213A1 Src kinase inhibitor compounds |
| 01/04/2001 | WO2000059449A3 Purine derivatives having phosphodiesterase iv inhibition activity |
| 01/04/2001 | WO2000039751A3 System and method for structure-based drug design that includes accurate prediction of binding free energy |
| 01/04/2001 | CA2383546A1 Src kinase inhibitor compounds |
| 01/04/2001 | CA2370500A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 01/03/2001 | EP1065208A1 Substituted purine derivatives as inhibitors of cell adhesion |
| 01/03/2001 | EP1065207A1 Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them |
| 01/02/2001 | CA2154721C 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
| 01/02/2001 | CA2095613C Substituted 1, 3-oxathiolanes and substituted 1, 3-dithiolanes with antiviral properties |
| 12/28/2000 | WO2000078777A1 Propargyl phenyl ether a2a receptor agonists |
| 12/27/2000 | EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
| 12/26/2000 | US6166199 Contacting purine with amino, hydrazine, hydroxylamine, thiol, semicarbazide, thiosemicarbazide, hydrazone, hydrazide, imidazole, tetrazole, triazole, pyrrolidine, piperidine, piperazine, morpholine, aldehyde, ketone, alcohol; antisense |
| 12/26/2000 | US6166016 Analgesics, anti-inflammatory agents, antimicrobial drugs, hypoglycemic agents, hypolipidemic agents, antihypertensive agents, anti-cancer agents |
| 12/26/2000 | US6165729 Electrochemiluminescent reaction utilizing amine-derived reductant |
| 12/26/2000 | CA2150671C Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections |
| 12/21/2000 | WO2000051993A3 Dihetero-substituted metalloprotease inhibitors |
| 12/14/2000 | WO2000075142A2 Dna methyltransferase inhibitors |
| 12/14/2000 | CA2373279A1 Dna methyltransferase inhibitors |
| 12/13/2000 | EP1059294A1 Procedure for the treatment of purines |
| 12/13/2000 | EP1058687A1 Nucleosides |
| 12/13/2000 | EP1058686A1 2'-fluoronucleosides |
| 12/13/2000 | CN1276370A Process for preparing anticancer compound, and intermediate |
| 12/12/2000 | US6159952 Bronchodilator agents |
| 12/07/2000 | WO2000073307A2 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors |
| 12/07/2000 | WO2000073306A1 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives |
| 12/07/2000 | CA2370598A1 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors |
| 12/06/2000 | EP1056745A2 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines |
| 12/06/2000 | EP1056744A1 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines |
| 12/06/2000 | CN1275983A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV) |
| 12/05/2000 | US6156893 Process for the preparation of (1S,4R)- or (1R,4S)- 4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol |
| 12/05/2000 | US6156892 Viricide intermediate, famciclovir and penciclovir. |
| 12/05/2000 | US6156766 Heterocyclic benzamides as drugs |
| 11/30/2000 | WO2000071543A1 Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 11/30/2000 | WO2000071523A1 Antibiotic prodrugs |
| 11/30/2000 | WO2000042989A3 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 11/30/2000 | CA2375066A1 Antibiotic prodrugs |
| 11/30/2000 | CA2374714A1 Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 11/29/2000 | EP1054891A1 Prodrugs |
| 11/29/2000 | EP1054871A2 Pyrimidines and triazines as integrin antagonists |
| 11/28/2000 | US6153618 For treating al alzheimer's disease |
| 11/28/2000 | US6153217 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents |
| 11/28/2000 | CA2068943C 1,3-oxathiolanes useful in the treatment of hepatitis |
| 11/23/2000 | WO2000069849A1 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
| 11/23/2000 | CA2373510A1 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
| 11/22/2000 | EP1054012A1 Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes |
| 11/21/2000 | US6150356 Potassium channel inhibitors and method |
| 11/21/2000 | US6150352 Antagonists of gonadotropin releasing hormone |
| 11/16/2000 | WO2000068231A1 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 11/16/2000 | WO2000068230A1 9-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,9-dihydropurin-6-one derivatives as pde7 inhibitors |
| 11/16/2000 | WO2000067801A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 11/16/2000 | WO2000020556A3 Zinc finger-reactive antimicrobial compounds |
| 11/16/2000 | CA2373015A1 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 11/16/2000 | CA2368831A1 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 11/14/2000 | CA2012432C N-(3-hydroxy-4piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin) carboxamide derivatives |
| 11/09/2000 | WO2000066128A1 Method of enhancing insulin action |